Pfizer Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	1,043	2,853	416	1,944
Short-Term Investments	-	19,434	9,837	22,316	29,125
Trading Asset Securities	-	-	-	-	4
Cash & Short-Term Investments	14,986	20,477	12,690	22,732	31,073
Cash Growth	-26.82%	61.36%	-44.18%	-26.84%	153.84%
Accounts Receivable	-	11,463	11,566	10,952	11,479
Other Receivables	-	3,314	3,978	3,577	4,266
Receivables	-	14,777	15,544	14,529	15,745
Inventory	-	10,851	10,189	8,981	9,059
Other Current Assets	-	4,253	4,910	5,017	3,816
Total Current Assets	-	50,358	43,333	51,259	59,693
Property, Plant & Equipment	-	20,682	21,864	19,276	17,721
Long-Term Investments	-	2,107	15,382	14,926	21,348
Goodwill	-	68,527	67,783	51,375	49,208
Other Intangible Assets	-	55,411	64,900	43,370	25,146
Long-Term Deferred Tax Assets	-	6,600	1,800	4,800	1,600
Other Long-Term Assets	-	9,711	11,439	12,199	6,760
Total Assets	-	213,396	226,501	197,205	181,476
Accounts Payable	-	5,633	6,710	6,809	5,578
Accrued Expenses	-	12,005	9,224	8,316	7,671
Short-Term Debt	-	3,199	8,096	385	605
Current Portion of Long-Term Debt	-	3,775	2,270	2,570	1,636
Current Portion of Leases	-	356	527	620	449
Current Income Taxes Payable	-	2,910	2,349	1,587	1,266
Current Unearned Revenue	-	1,511	2,700	2,520	3,067
Other Current Liabilities	-	13,606	15,918	19,331	22,399
Total Current Liabilities	-	42,995	47,794	42,138	42,671
Long-Term Debt	-	57,802	61,813	33,205	36,195
Long-Term Leases	-	2,286	2,626	2,597	2,510
Pension & Post-Retirement Benefits	-	2,115	2,167	2,250	3,724
Long-Term Deferred Tax Liabilities	-	2,122	640	1,023	349
Other Long-Term Liabilities	-	17,579	22,173	20,075	18,564
Total Liabilities	-	124,899	137,213	101,288	104,013
Common Stock	-	480	478	476	473
Additional Paid-In Capital	-	93,603	92,631	91,802	90,591
Retained Earnings	-	116,725	118,353	125,656	103,394
Treasury Stock	-	-114,763	-114,487	-113,969	-111,361
Comprehensive Income & Other	-	-7,842	-7,961	-8,304	-5,896
Total Common Equity	92,801	88,203	89,014	95,661	77,201
Minority Interest	-	294	274	256	262
Shareholders' Equity	93,096	88,497	89,288	95,917	77,463
Total Liabilities & Equity	-	213,396	226,501	197,205	181,476
Total Debt	61,938	67,418	75,332	39,377	41,395
Net Cash (Debt)	-46,952	-46,941	-62,642	-16,645	-10,322
Net Cash Per Share	-8.22	-8.24	-10.97	-2.90	-1.81
Filing Date Shares Outstanding	5,686	5,667	5,647	5,619	5,623
Total Common Shares Outstanding	5,686	5,667	5,646	5,616	5,620
Working Capital	-	7,363	-4,461	9,121	17,022
Book Value Per Share	16.32	15.56	15.77	17.03	13.74
Tangible Book Value	-27,624	-35,735	-43,669	916	2,847
Tangible Book Value Per Share	-4.86	-6.31	-7.73	0.16	0.51
Land	-	291	353	368	423
Buildings	-	9,036	9,046	8,832	9,001
Machinery	-	20,612	19,661	17,373	16,710
Construction In Progress	-	4,937	5,925	4,875	3,822

Source: S&P Global Market Intelligence. Standard template. Financial Sources.